Long‐term management of atrial fibrillation

Por John Camm, A., Gallagher, Mark M., John Camm, A.
Publicado no Clin Cardiol (2009)

Atrial Fibrillation and Risk

Por John Camm, A.
Publicado no Clin Cardiol (2012)

Atrial fibrillation: Is there a role for low‐molecular‐weight heparin?

Por John CAMM, A.
Publicado no Clin Cardiol (2009)

The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?

Por A, John Camm MD
Publicado em 2014

Clinical relevance of heart rate variability

Por Kautzner, Josef, John Camm, A.
Publicado no Clin Cardiol (2009)

Special considerations for therapeutic choice of non–vitamin K antagonist oral anticoagulants for Japanese patients with nonvalvular atrial fibrillation

Por Okumura, Ken, Hori, Masatsugu, Tanahashi, Norio, John Camm, A.
Publicado no Clin Cardiol (2016)

Transvenous atrial defibrillation—techniques and clinical applications

Por Tse, Hung‐Fat, Lau, Chu‐Pak, John Camm, A.
Publicado no Clin Cardiol (2009)

Correlation of coronary angiography with “tombstoning” electrocardiographic pattern in patients after acute myocardial infarction

Por Guo, Xiao Hua, Guan, Yee, Chen, Li Jia, Huang, Jian, John Camm, A.
Publicado no Clin Cardiol (2009)

Irregularity of the ventricular rhythm during atrial fibrillation: Effect of slow atrioventricular nodal pathway ablation

Por John Camm, A., Frey, Bernhard, Kreiner, Gerhard, Gössinger, Heinz David, Liebisch, Bernhard, Sauermann, Stefan
Publicado no Clin Cardiol (2009)

Relation of ventricular repolarization to cardiac cycle length in normal subjects, hypertrophic cardiomyopathy, and patients with myocardial infarction

Por Savelieva, Irina, Yap, Yee Guan, Yi, Gang, Guo, Xiao Hua, Hnatkova, Katerina, John Camm, A., Malik, Marek
Publicado no Clin Cardiol (2009)

Clinical approaches to tachyarrhythmias, volume 10: The brugada syndrome

Por John Camm, A., Antzelevitch, Charles, Brugada, Pedro, Brugada, Josep, Brugada, Ramon, Nademanee, Koonlawee, Towbin, Jeffrey, Curtis, Anne B.
Publicado no Clin Cardiol (2009)

Evaluating the place of low‐molecular‐weight heparin in the management of acute coronary syndromes

Por Chesebro, James H., Verheugt, FREEK W. A., Kontny, Frederic, Fry, EDWARD T. A., Wallentin, Lars, John CAMM, A., Bechtold, Heinrich
Publicado no Clin Cardiol (2009)

Effects of Rivaroxaban on Biomarkers of Coagulation and Inflammation: A Post Hoc Analysis of the X-VeRT Trial

Por Paulus Kirchhof, Michael D. Ezekowitz, Yanish Purmah, Sonja Schiffer, Isabelle L. Meng, A. John Camm, Stefan H. Hohnloser, Anke Schulz, Melanie Wosnitza, Riccardo Cappato
Publicado em 2020-01-01

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

Por Jan Beyer-Westendorf, A. John Camm, Keith A. A. Fox, Jean-Yves Le Heuzey, Sylvia Haas, Alexander G. G. Turpie, Saverio Virdone, Ajay K. Kakkar, for the RIVER Registry Investigators
Publicado em 2019-04-01

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Por Sawhney, Jitendra PS., Kothiwale, Veerappa A., Bisne, Vikas, Durgaprasad, Rajashekhar, Jadhav, Praveen, Chopda, Manoj, Vanajakshamma, Velam, Meena, Ramdhan, Vijayaraghavan, Govindan, Chawla, Kamaldeep, Allu, Jagan, Pieper, Karen S., John Camm, A., Kakkar, Ajay K.
Publicado no Indian Heart J (2018)

2015 ESC GUIDELINES FOR THE MANAGEMENT OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS AND THE PREVENTION OF SUDDEN CARDIAC DEATH

Por Priori G. Silvia, Blomström-Lundqvist Carina, Andrea Mazzanti†, Nico Bloma, Martin Borggrefe, John Camm, Perry Mark Elliott, Donna Fitzsimons, Robert Hatala, Gerhard Hindricks, Paulus Kirchhof, Keld Kjeldsen, Karl-Heinz Kuck, Antonio Hernandez, Nikolaos Nikolaou, Tone M. Norekvål, Christian Spaulding, Dirk J. Van Veldhuisen
Publicado em 2016-07-01

Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.

Por Sylvia Haas, Hugo Ten Cate, Gabriele Accetta, Pantep Angchaisuksiri, Jean-Pierre Bassand, A John Camm, Ramon Corbalan, Harald Darius, David A Fitzmaurice, Samuel Z Goldhaber, Shinya Goto, Barry Jacobson, Gloria Kayani, Lorenzo G Mantovani, Frank Misselwitz, Karen Pieper, Sebastian M Schellong, Janina Stepinska, Alexander G G Turpie, Martin van Eickels, Ajay K Kakkar, GARFIELD-AF Investigators
Publicado em 2016-01-01

A statement on ethics from the HEART Group

Por Ector, Hugo, Lancellotti, Patrizio, Roberts, William C., Wenger, Nanette K., Moss, Arthur J., Smith, Eldon R., Borer, Jeffrey S., Eagle, Kim A., Freedman, Jane, Krum, Henry, Lang, Chim, Remme, Willem J., Piper, Hans Michael, White, Christopher J., Loscalzo, Joseph, Marbán, Eduardo, Sobel, Burton E., Roberts, Robert, Shahbudin H., Rahimtoola, A. John, Camm, Van de Werf, Frans, Swedberg, Karl, Timmis, Adam D., Stone, Kathleen S., Zipes, Douglas P., Iosseliani, David G., Taylor, Allen J., Rosen, Michael R., Grines, Cindy L., DeMaria, Anthony N., Narula, Jagat, King III, Spencer B., Wagner, Galen S., Saksena, Sanjeev, Pearlman, Alan S., Bodnar, Endre, Emery, Robert W., Cohn, Lawrence H., van der Wall, Ernst E., Ra-id, Adbulla, Lesch, Michael, Alfonso, Fernando, Ekroth, Rolf
Publicado em 2008